Recently published research showcased the use of a technique called proximity extension assay (PEA) to identify proteins that are significantly elevated in the urine of lupus patients with active renal disease; furthermore, this technique identified six urine protein biomarkers indicative of lupus that had not been reported.
“This latest study adds several additional biomarker candidates that can potentially be used to track disease activity in lupus noninvasively,” lead researcher